Filing Details

Accession Number:
0001225208-12-015065
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-06-29 19:22:13
Reporting Period:
2012-06-29
Filing Date:
2012-06-29
Accepted Time:
2012-06-29 18:22:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346974 M Thomas Abate One Edwards Way
Irvine CA 92614
Cvp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-06-29 15,000 $21.50 61,366 No 4 M Direct
Common Stock Disposition 2012-06-29 200 $103.47 61,166 No 4 S Direct
Common Stock Disposition 2012-06-29 14,800 $103.00 46,366 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2012-06-29 15,000 $0.00 15,000 $21.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
35,000 2007-02-15 2013-02-15 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 31, 2012.
  2. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
  3. This transaction was executed in multiple trades at prices ranging from $102.40 to $103.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.